Teva Pharmaceuticals USA, Inc., et al v. Robert Kennedy, Jr., et al
| Teva Pharmaceuticals USA, Inc., Teva Branded Pharmaceutical Products R&D, Inc and Teva Neuroscience, Inc. |
| Robert F. Kennedy, Jr., in his official capacity as Secretary of Health and Human Services and Mehmet Oz, in his official capacity as Administrator of the Centers for Medicare & Medicaid Services |
| Association for Accessible Medicines, Bausch Health Companies, Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Sanofi-Aventis U.S. LLC, Biotechnology Innovation Organization, Public Citizen, Doctors for America, Protect Our Care, Families USA, AARP, AARP Foundation, Center for Medicare Advocacy, Medicare Rights Center Inc., Justice in Aging and Patients for Affordable Drugs |
| 25-5425 |
| November 30, 2025 |
| U.S. Court of Appeals, D.C. Circuit |
| Other Statutes APA/Review Agency |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 19, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| RESPONSE [2174142] to letter Rule 28j authorities [ # 2173860-2 ], letter [ # 2173860-3 ] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 05/19/2026 by CM/ECF NDA] Length Certification: 291 Words. [25-5425] (Marotta, Sean) [Entered: 05/19/2026 03:10 PM] |
| LETTER [2173860] pursuant to FRAP 28j advising of additional authorities filed by Robert F. Kennedy, Jr. and Mehmet Oz [Service Date: 05/18/2026 ] [25-5425] (Baldi, Maxwell) [Entered: 05/18/2026 02:22 PM] |
| ORAL ARGUMENT HELD before Judges Henderson, Childs and Pan. [25-5425] [Entered: 05/05/2026 01:30 PM] |
| FORM 72 submitted by arguing attorney, Sean Marotta, on behalf of Appellants Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc. and Teva Branded Pharmaceutical Products R&D, Inc (For Internal Use Only: Form is restricted to protect counsel's personal contact information) . [25-5425] (Marotta, Sean) [Entered: 04/24/2026 10:37 AM] |
| FORM 72 submitted by arguing attorney, Maxwell A. Baldi, on behalf of Appellees Robert F. Kennedy, Jr. and Mehmet Oz (For Internal Use Only: Form is restricted to protect counsel's personal contact information) . [25-5425] (Baldi, Maxwell) [Entered: 04/24/2026 09:57 AM] |
| PER CURIAM ORDER [2170143] filed allocating oral argument time as follows: Appellants - 15 Minutes, Appellees - 15 Minutes. One counsel per side to argue; directing party to file Form 72 notice of arguing attorney by 04/27/2026 [25-5425] [Entered: 04/23/2026 03:28 PM] |
| APPELLANT REPLY BRIEF [2166401] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 03/31/2026 ] Length of Brief: 6,493 words. [25-5425] (Marotta, Sean) [Entered: 03/31/2026 04:16 PM] |
| NOTICE [2165769] of intention to participate as amicus curiae [Disclosure Listing: Not Applicable to this Party] filed by Patients for Affordable Drugs [Service Date: 03/26/2026 ] [25-5425]--[Edited 03/30/2026 by LMF] (Gerstein, Charles) [Entered: 03/26/2026 01:23 PM] |
| CLERK'S ORDER [2164549] filed scheduling oral argument on Tuesday, 05/05/2026. [25-5425] [Entered: 03/19/2026 06:52 PM] |
| AMICUS FOR APPELLEE BRIEF [2164153] filed by Patients for Affordable Drugs [Service Date: 03/17/2026 ] Length of Brief: 5545 words.. [25-5425] (Gerstein, Charles) [Entered: 03/17/2026 07:07 PM] |
| CONSENT AMICUS FOR APPELLEE BRIEF [2164142] filed by AARP Foundation and AARP AARP, AARP FOUNDATION, JUSTICE IN AGING, THE CENTER FOR MEDICARE ADVOCACY, AND THE MEDICARE RIGHTS CENTER [Service Date: 03/17/2026 ] Length of Brief: 6423 words. [25-5425] (Gyamfi, Maame) [Entered: 03/17/2026 05:45 PM] |
| CONSENT ENTRY OF APPEARANCE [2164138] filed by Maame Gyamfi on behalf of Amicus Curiae for Appellee AARP Foundation. [25-5425] (Gyamfi, Maame) [Entered: 03/17/2026 05:31 PM] |
| ENTRY OF APPEARANCE [2163932] filed by Nandan M. Joshi and co-counsel Wendy Liu on behalf of Amici Curiae for Appellee Doctors for America, Families USA, Public Citizen and Protect Our Care. [25-5425] (Joshi, Nandan) [Entered: 03/17/2026 08:15 AM] |
| AMICUS FOR APPELLEE BRIEF [2163930] filed by Families USA, Doctors for America, Public Citizen and Protect Our Care [Service Date: 03/17/2026 ] Length of Brief: 6057 words. [25-5425] (Joshi, Nandan) [Entered: 03/17/2026 08:14 AM] |
| LETTER [2163001] advising of arguing counsel's availability for oral argument filed by Robert F. Kennedy, Jr. and Mehmet Oz [Service Date: 03/10/2026 ] [25-5425] (Baldi, Maxwell) [Entered: 03/10/2026 03:44 PM] |
| APPELLEE BRIEF [2163000] filed by Robert F. Kennedy, Jr. and Mehmet Oz [Service Date: 03/10/2026 ] Length of Brief: 11,789 words. [25-5425] (Baldi, Maxwell) [Entered: 03/10/2026 03:43 PM] |
| LETTER [2162935] advising of arguing counsel's availability for oral argument filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc. [Service Date: 03/10/2026 ] [25-5425] (Marotta, Sean) [Entered: 03/10/2026 01:29 PM] |
| NOTICE [2161605] of intention to participate as amicus curiae [Disclosure Listing: Attached] filed by AARP, AARP FOUNDATION, CENTER FOR MEDICARE ADVOCACY, AND MEDICARE RIGHTS CENTER [Service Date: 03/02/2026 ] [25-5425]--[Edited 03/03/2026 by LMF] (Gyamfi, Maame) [Entered: 03/02/2026 11:45 AM] |
| NOTICE [2160356] of intention to participate as amicus curiae [Disclosure Listing: Attached] filed by Public Citizen, Doctors for America, Protect Our Care, and Families USA [Service Date: 02/23/2026 ] [25-5425]--[Edited 02/23/2026 by LMF] (Joshi, Nandan) [Entered: 02/23/2026 08:54 AM] |
| NOTICE [2155024] of intention to participate as amicus curiae [Disclosure Listing: Attached] filed by Bausch Health Companies Inc.; Bristol Myers Squibb Company; Eli Lilly and Company; Johnson & Johnson; Sanofi-Aventis U.S. LLC; and Biotechnology Innovation Organization [Service Date: 01/20/2026 ] [25-5425] (Royzman, Irena) [Entered: 01/20/2026 08:38 PM] |
| CORRECTED AMICUS FOR APPELLANT BRIEF [2154852] filed by Association for Accessible Medicines [Service Date: 01/20/2026 ] Length of Brief: 6,418 words. [25-5425] (Burgess, Brian) [Entered: 01/20/2026 01:29 PM] |
| CONSENT AMICUS FOR APPELLANT BRIEF [2154716] filed by Bausch Health Companies Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Sanofi-Aventis U.S. LLC, and Biotechnology Innovation Organization [Service Date: 01/16/2026 ] Length of Brief: 6,478 words. [25-5425] (Royzman, Irena) [Entered: 01/16/2026 05:37 PM] |
| AMICUS FOR APPELLANT BRIEF [2154689] filed by Association for Accessible Medicines [Service Date: 01/16/2026 ] Length of Brief: 6,418 words. [25-5425] (Burgess, Brian) [Entered: 01/16/2026 03:48 PM] |
| NOTICE [2154047] of intention to participate as amicus curiae [Disclosure Listing: Attached] filed by Association for Accessible Medicines [Service Date: 01/13/2026 ] [25-5425]--[Edited 01/14/2026 by LMF] (Burgess, Brian) [Entered: 01/13/2026 02:07 PM] |
| APPENDIX [2153663] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Volumes: 1] [Service Date: 01/09/2026 ] [25-5425] (Marotta, Sean) [Entered: 01/09/2026 06:57 PM] |
| APPELLANT BRIEF [2153662] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 01/09/2026 ] Length of Brief: 12,998 words. [25-5425] (Marotta, Sean) [Entered: 01/09/2026 06:57 PM] |
| CERTIFICATE AS TO PARTIES, RULINGS AND RELATED CASES [2148733] filed by Robert F. Kennedy, Jr. and Mehmet Oz [Service Date: 12/04/2025 ] [25-5425] (Baldi, Maxwell) [Entered: 12/04/2025 03:40 PM] |
| CLERK'S ORDER [2148706] filed considering motion to expedite case [ # 2148160-2 ], setting briefing schedule: APPELLANT Brief due 01/09/2026. APPENDIX due 01/09/2026. APPELLEE Brief due on 03/10/2026. APPELLANT Reply Brief due 03/31/2026 [25-5425] [Entered: 12/04/2025 02:58 PM] |
| STATEMENT OF INTENT REGARDING APPENDIX DEFERRAL [2148158] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ] Intent: AppxNotDeferred [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:30 PM] |
| TRANSCRIPT STATUS REPORT [2148149] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ]. Status of Transcripts: Final - No transcripts are needed for the appeal. [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:23 PM] |
| ENTRY OF APPEARANCE [2148146] filed by Sean Marotta and co-counsel Danielle Desaulniers Stempel, Dana A. Raphael, Katherine T. McKay on behalf of Appellants Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc.. [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:19 PM] |
| DOCKETING STATEMENT [2148148] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ] [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:21 PM] |
| EMERGENCY UNOPPOSED MOTION [2148160] to expedite case filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ] Length Certification: 1,305 words. [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:34 PM] |
| CERTIFICATE AS TO PARTIES, RULINGS AND RELATED CASES [2148150] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ] [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:26 PM] |
| UNDERLYING DECISION IN CASE [2148155] submitted by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ] [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:27 PM] |
| STATEMENT OF ISSUES [2148156] filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc. [Service Date: 12/02/2025 ] [25-5425] (Marotta, Sean) [Entered: 12/02/2025 01:29 PM] |
| CLERK'S ORDER [2147669] filed directing party to file initial submissions: APPELLANT docketing statement due 12/31/2025. APPELLANT certificate as to parties due 12/31/2025. APPELLANT statement of issues due 12/31/2025. APPELLANT underlying decision due 12/31/2025. APPELLANT deferred appendix statement due 12/31/2025. APPELLANT entry of appearance due 12/31/2025. APPELLANT transcript status report due 12/31/2025. APPELLANT procedural motions due 12/31/2025. APPELLANT dispositive motions due 01/15/2026; directing party to file initial submissions: APPELLEE certificate as to parties due 12/31/2025. APPELLEE entry of appearance due 12/31/2025. APPELLEE procedural motions due 12/31/2025. APPELLEE dispositive motions due 01/15/2026 [25-5425] [Entered: 12/01/2025 09:24 AM] |
| ENTRY OF APPEARANCE [2147726] filed by Maxwell A. Baldi and co-counsel Michael S. Raab on behalf of Appellees Robert F. Kennedy, Jr. and Mehmet Oz. [25-5425] (Baldi, Maxwell) [Entered: 12/01/2025 10:59 AM] |
| NOTICE OF APPEAL [2147667] seeking review of a decision by the U.S. District Court in 1:25-cv-00113-SLS filed by Teva Branded Pharmaceutical Products R&D, Inc, Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc.. Appeal assigned USCA Case Number: 25-5425. [25-5425] [Entered: 12/01/2025 09:23 AM] |
| US CIVIL CASE docketed. [25-5425] [Entered: 12/01/2025 09:20 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
